Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengkun Yang

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Biology|September 4, 2025
Genome-Wide Identification, Characterization, and Expression Analysis of <i>BBX</i> Genes During Anthocyanin Biosynthesis in Mango (<i>Mangifera indica</i> L.)Chengkun Yang, Muhammad Mobeen Tahir, Yawen Zhang, et al.
Annals of Translational Medicine|January 24, 2022
Molecular mechanism of CK19 involved in the regulation of postoperative recurrence of HBV-associated primary hepatocellular carcinoma in GuangxiHao Su, Chuangye Han, Yongfei He, et al.
Cancer Management and Research|September 21, 2018
Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomyXiwen Liao, Chuangye Han, Xiangkun Wang, et al.
Cancer Management and Research|August 22, 2018
Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomyXiwen Liao, Xiangkun Wang, Ketuan Huang, et al.
Cancer Management and Research|May 2, 2018
Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinomaXiwen Liao, Guangzhi Zhu, Rui Huang, et al.
Cancer Management and Research|May 16, 2018
Genome-wide association pathway analysis to identify candidate single nucleotide polymorphisms and molecular pathways associated with TP53 expression status in HBV-related hepatocellular carcinomaXiwen Liao, Long Yu, Xiaoguang Liu, et al.
Oncotargets and Therapy|October 6, 2017
Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomyXiwen Liao, Ketuan Huang, Rui Huang, et al.
Pharmacogenomics and Personalized Medicine|April 5, 2022
Acyl-CoA Binding Domain Containing 4 Polymorphism rs4986172 and Expression Can Serve as Overall Survival Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients After HepatectomyHuasheng Huang, Xiwen Liao, Guangzhi Zhu, et al.
Oncology Reports|May 7, 2019
Cystatin F as a key family 2 cystatin subunit and prognostic biomarker for early‑stage pancreatic ductal adenocarcinomaChengkun Yang, Tingdong Yu, Zhengqian Liu, et al.
Cancer Management and Research|July 10, 2018
The prognostic value of differentially expressed CYP3A subfamily members for hepatocellular carcinomaTingdong Yu, Xiangkun Wang, Guangzhi Zhu, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Biology|September 4, 2025
Genome-Wide Identification, Characterization, and Expression Analysis of <i>BBX</i> Genes During Anthocyanin Biosynthesis in Mango (<i>Mangifera indica</i> L.)Chengkun Yang, Muhammad Mobeen Tahir, Yawen Zhang, et al.
Annals of Translational Medicine|January 24, 2022
Molecular mechanism of CK19 involved in the regulation of postoperative recurrence of HBV-associated primary hepatocellular carcinoma in GuangxiHao Su, Chuangye Han, Yongfei He, et al.
Cancer Management and Research|September 21, 2018
Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomyXiwen Liao, Chuangye Han, Xiangkun Wang, et al.
Cancer Management and Research|August 22, 2018
Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomyXiwen Liao, Xiangkun Wang, Ketuan Huang, et al.
Cancer Management and Research|May 2, 2018
Identification of potential prognostic microRNA biomarkers for predicting survival in patients with hepatocellular carcinomaXiwen Liao, Guangzhi Zhu, Rui Huang, et al.
Cancer Management and Research|May 16, 2018
Genome-wide association pathway analysis to identify candidate single nucleotide polymorphisms and molecular pathways associated with TP53 expression status in HBV-related hepatocellular carcinomaXiwen Liao, Long Yu, Xiaoguang Liu, et al.
Oncotargets and Therapy|October 6, 2017
Genome-scale analysis to identify prognostic markers in patients with early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomyXiwen Liao, Ketuan Huang, Rui Huang, et al.
Pharmacogenomics and Personalized Medicine|April 5, 2022
Acyl-CoA Binding Domain Containing 4 Polymorphism rs4986172 and Expression Can Serve as Overall Survival Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients After HepatectomyHuasheng Huang, Xiwen Liao, Guangzhi Zhu, et al.
Oncology Reports|May 7, 2019
Cystatin F as a key family 2 cystatin subunit and prognostic biomarker for early‑stage pancreatic ductal adenocarcinomaChengkun Yang, Tingdong Yu, Zhengqian Liu, et al.
Cancer Management and Research|July 10, 2018
The prognostic value of differentially expressed CYP3A subfamily members for hepatocellular carcinomaTingdong Yu, Xiangkun Wang, Guangzhi Zhu, et al.
Pageof 8